The role of 99mTc-tetrofosmin pinhole-SPECT in breast cancer nonpalpable axillary lymph node metastases detection

Quarterly Journal of Nuclear Medicine

Volumn 47, Issue 2, 2003, Pages 116-128

  Spanu, A ^a   Tanda, F ^a   Dettori, G ^a   Manca, A ^a   Chessa, F ^a   Porcu, A ^a   Falchi, A ^a   Nuvoli, S ^a   Madeddu, G ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Breast neoplasms, radionuclide imaging; Lymph nodes; Lymphatic metastasis; Radiopharmaceuticals; Technetium Tc 99m sestamibi; Tomography, emission computed, single photon

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL TRIAL; COLLIMATOR; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; NON INVASIVE MEASUREMENT; PALPATION; PINHOLE SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PALPATION; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0041523957     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fisher B, Bauer M, Wickherham DL, Redmon C, Fisher E. Relation of number of positive axillary nodes to the prognosis of patients with primary breast carcinoma: An NSABP update. Cancer 1983;52:1551-7.
2. Kissin MW, Querci Della Rovere G, Easton D, Westbury G. Risk of lymphoedema following in the treatment of breast cancer. Br J Surg 1986;73:580-4.
3. Carter C, Allen C, Henson D. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
4. Bucalossi P, Veronesi U, Zingo L, Cantu C. Enlarged mastectomy for breast cancer: Review of 1213 cases. Am J Roentgenol Radium Ther Nucl Med 1971;111:119-22.
5. Schottenfeld D, Nash A, Robbins G, Beattie EJ Jr. Ten-year results of the treatment of primary operable breast carcinoma: A summary of 304 patients evaluated by the TNM system. Cancer 1976;38:1001-7.
6. Walsh R, Kornguth PJ, Soo MS, Bentley R, DeLong DM. Axillary lymph nodes: Mammographic, pathologic and clinical correlations. Am J Roentgenol 1997;168:33-8.
7. Yang WT, Chang J, Metreweli C. Patients with breast cancer: Differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes. Radiology 2000;215:568-73.
8. Yoshimura G, Sakurai T, Oura S, Suzuma T, Tamaki T, Umemura T et al. Evaluation of axillary lymph node status in breast cancer with MRI. Breast Cancer 1999;25:249-58.
9. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-8.
10. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N et al. Lympathic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
11. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-1887.
12. Borgstein PJ, Pijpers R, Comans EF, Van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and γ probe detection. J Am Coll Surg 1998;186:275-83.
13. Utech CI, Young CS, Winter PF. Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. Eur J Nucl Med 1996;23:1588-93.
14. Adler LP, Faulhaber PF, Schnur KC, Al-Kasi NL, Shenk RR. Axillary lymph node metastases: Screening with [F-18] 2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 1997;203:323-7.
15. Smith IC, Ogston KN, Whitford P, Smith FW, Sharp P, Norton M et al. Staging of the axilla in breast cancer: Accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. Ann Surg 1998;228:220-7.
16. Hubner KF, Smith GT, Thie JA, Bell JL, Nelson HS, Hanna WT. The potential of F-18-FDG PET in breast cancer. Detection of primary lesions, axillary lymph nodes metastases, or distant metastases. Clin Positron Imaging 2000;3:197-205.
17. Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Giovanazzi R et al. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: Clinical evaluation and alternative management. J Natl Cancer Inst 2001;18:630-5.
18. Schillaci O, Scopinaro F,Tavolaro R, Cannas P, Picardi V et al. Technetium-99m sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer. Anticancer Res 1997;17:1607-10.
19. 99mTc-tetrofomin SPET in the detection of both primary breast cancer and axillary lymph node metastasis. Eur J Nucl Med 2001;28:1781-94.
20. 99m-Tc-Tetrofosmin pinhole-SPECT in breast cancer axillary lymph node staging. Cancer Biother Radiopharm 2000;15:81-91.
21. Wenet PM, Sand A, Abramovici J. Physical and clinical evaluation of high-resolution thyroid pinhole tomography. J Nucl Med 1996;37:2017-20.
22. Chiaramida P, Spanu A, Madeddu G. 180° Pinhole (P) SPECT and 360° (C) SPECT spatial resolution. An experimental model [abstract]. Q J Nucl Med 1998;42 Suppl:11P.
23. Scarfone C, Jaszczak RJ, Li J, Soo MS, Smith MF, Greer KL et al. Breast tumour imaging using incomplete circular orbit pinhole SPECT: A phantom study. Nucl Med Commun 1997;18:1077-86.
24. Vanhove C, Defrise M, Franken PR, Everaert H, Deconinck F, Bossuyt A. Interest of the ordered subsets expectation maximization (OS-EM) algorithm in pinhole single-photon emission tomography reconstruction: A phantom study. Eur J Nucl Med 2000;27:140-6.
25. 99mTc-Tetrosfomin Pinhole-SPECT (P-SPECT) and radioguided' sentinel node (SN) biopsy and in breast cancer axillary lymph node staging. Cancer Biother Radiopharm 2001;16:501-13.